MOLECULAR MECHANISM OF T LYMPHOCYTE ACTIVATION
T淋巴细胞激活的分子机制
基本信息
- 批准号:5200811
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:CD3 molecule T cell receptor T lymphocyte antireceptor antibody antiserum calcium flux chimeric proteins clone cells enzyme activity gene expression glutathione transferase human T cell leukemia inositol intermolecular interaction isozymes leukocyte activation /transformation phospholipase C phospholipids phosphoproteins precipitation protein kinase C protein tyrosine kinase protooncogene receptor coupling
项目摘要
Perturbation of the T cell receptor (TCR)/CD3 complex by antigen in the
context of the appropriate MHC or by anti-receptor antibodies (Ab)
initiates a cascade of events which include protein tyrosine kinase
activation, the phosphorylation of an inositol phospholipid
(InsPL)-specific phospholipase C (PLC) isozyme, PLCgamma-1, activation
of InsPL hydrolysis, and the generation of second messengers that control
protein kinase C activation and Ca2+ mobilization. PLCgamma-1 contains
a number of independent sub-domains, including src-homology (SH) and
plekstrin-homology (PH) domains. These domains function as docking sites
in protein/protein interactions and are likely to play a critical role
in coupling PLCgamma-1 to the TCR/CD3 complex and in regulating its
activity. Recombinant glutathione S-transferase fusion proteins
encompassing individual or multiple PLCgamma-1 sub-domains were used to
screen for binding proteins. A number of phosphoproteins interacting
specifically with individual SH domains were detected. A phosphoproteins
of 120 kDa binding to the SH3 domain was identified as the protein
product of the c-cbl proto-oncogene, a protein of unknown function, but
involved in early activation events in response to TCR signaling, as
indicated by its rapid phosphorylation by tyrosine kinases in response
to mitogens or antibody-mediated ligation of the receptor. The
interaction between the two native proteins was demonstrated by
co-precipitating PLCgamma-1 with an anti-serum directed against p120c-cbl
and blocking with an SH3-binding peptide. High level of expression of
c-cbl in transiently transfected human Jurkat T leukemia cells have been
obtained and will be used a as model to assess p120c-cbl function. In
addition, transient expression in Jurkat cells of PLCgamma-1 SH
subdomains as independent proteins has been obtained and will be used in
conjunction with the expression of PLCgamma-1 SH mutants to asses their
role in protein/protein interactions in vivo and T cell activation.
T细胞受体(TCR)/CD3复合体受抗原干扰的研究
适当的MHC的背景或通过抗受体抗体(Ab)
启动一系列事件,包括蛋白酪氨酸激酶
肌醇磷脂的活化、磷酸化
(InsPL)特异性磷脂酶C(PLC)同工酶,PLC,Gamma-1,激活
InsPL水解和控制第二信使的产生
蛋白激酶C的激活与钙离子动员。PLC Gamma-1含有
一些独立的子域,包括src同源(SH)和
Plekstrin同源(PH)结构域。这些域起到停靠站点的作用
在蛋白质/蛋白质的相互作用中,很可能发挥关键作用
在将PLCGamma-1偶联到TCR/CD3复合体并调节其
活动。重组谷胱甘肽S-转移酶融合蛋白
包括单个或多个PLCGamma-1亚域用于
筛选结合蛋白。多个相互作用的磷酸蛋白
特异性地检测到单个SH结构域。A磷蛋白
与SH3结构域结合的120 kDa为该蛋白
原癌基因c-cbl的产物,一种功能未知的蛋白质,但
参与响应TCR信号的早期激活事件,AS
通过酪氨酸激酶的快速磷酸化反应来指示
到有丝分裂原或抗体介导的受体连接。这个
这两种天然蛋白质之间的相互作用通过
P120c-CBL抗血清与PLCGamma-1共沉淀
并用SH3结合的多肽进行阻断。高水平的表达
C-CBL在瞬时转染人Jurkat T白血病细胞中的表达
获得并将用于评估p120c-CBL功能的AS模型。在……里面
另外,PLC-1 SH在Jurkat细胞中的瞬时表达
已经获得了作为独立蛋白质的亚域,并将用于
结合PLCGamma-1 SH突变体的表达
在体内蛋白质/蛋白质相互作用和T细胞激活中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
E BONVINI其他文献
E BONVINI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('E BONVINI', 18)}}的其他基金
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLCR1 ACTIVATION
T淋巴细胞激活机制--PLCR1激活的调控
- 批准号:
2569028 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
- 批准号:
6101290 - 财政年份:
- 资助金额:
-- - 项目类别:
ROLE OF G-PROTEINS IN THE CONTROL OF INOSITOL PHOSPHOLIPID HYDROLYSIS IN T-CELLS
G 蛋白在控制 T 细胞中肌醇磷脂水解中的作用
- 批准号:
3811105 - 财政年份:
- 资助金额:
-- - 项目类别:
SIGNAL TRANSDUCTION VIA THE T CELL RECEPTOR /CD3 COMPLEX
通过 T 细胞受体 /CD3 复合物进行信号转导
- 批准号:
3804896 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
- 批准号:
6161348 - 财政年份:
- 资助金额:
-- - 项目类别:
ANALYSIS OF INOSITOL PHOSPHATE METABOLISM IN T LYMPHOCYTES BY HPLC
HPLC分析磷酸肌醇在T淋巴细胞中的代谢
- 批准号:
3811108 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
-- - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
-- - 项目类别: